CenterHigh
KABC / ABC7 Los AngelesNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
← Today's headlines
9 sources checked · Left, Center, and Right included · Just now
Mostly Same
FDA approves Moderna's m RNA seasonal flu vaccine
All headlines are identical, reporting the FDA's approval of Moderna's m RNA seasonal flu vaccine.
1 Left6 Center2 Right
MOSTLY SAME
As of August 6, 2026 at 9:33 AM, this is how Optics News reads the wording differences in this story.
What happened The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence High confidence. 9 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh
9 sources across Left, Center, and Right all describe the same event.
Framing confidenceMostly same
0/99 — the outlets mostly agree on the headline takeaway.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA approves Moderna's m RNA flu vaccine after initial pushback
CBS News · Center-left · News report
CenterFDA approves Moderna's m RNA seasonal flu vaccine
KABC / ABC7 Los Angeles · Center · News report
Right / center-rightMorning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
American Greatness · Right · News report
SEE THE HEADLINES
Open source
CenterHigh
WLS / ABC7 ChicagoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KGO / ABC7 San FranciscoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
WPVI / 6abc PhiladelphiaNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KTRK / ABC13 HoustonNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
RightMixed
American GreatnessNews report · Aug 6, 9:02 AM
Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
Good Thursday morning. Here is what’s on President Trump’s agenda today: 8:00 AM THE PRESIDENT participates in Executive Time 10:00 AM THE PRESIDENT participates in […] Source
Show all 9 sources
CenterMostly Factual
ForbesNews report · Aug 6, 6:44 AM
FDA Approves First m RNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
RightLow
100 Percent Fed UpNews report · Aug 6, 5:32 AM
FDA Approves New m RNA Jab
The Food and Drug Administration (FDA) on Wednesday approved the first influenza jab in the United States to use m RNA […]
Center-leftHigh
CBS NewsNews report · Aug 6, 3:33 AM
FDA approves Moderna's m RNA flu vaccine after initial pushback
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses m RNA technology, the drugmaker announced.
Details0/99 Wording Gap · High confidence · 9 sources
0/99 Wording GapHigh confidence9 sources · 3 bias bucketsStable · 9 sources · all three buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Aug 6, 3:33 AM: CBS News joined the source map.
Aug 6, 5:32 AM: 100 Percent Fed Up joined the source map.
Aug 6, 6:44 AM: Forbes joined the source map.
Aug 6, 9:02 AM: American Greatness joined the source map.
Now: Wording Gap is 0/99 and story health is stable · 9 sources · all three buckets · comparable news format.